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Variations in Respiratory Excretion of Carbon Dioxide Can 
Be Used to Calculate Pulmonary Blood Flow
David A. Preissa, Takafumi Azamib, Richard D. Urmanc, d
Abstract
Background: A non-invasive means of measuring pulmonary blood 
flow (PBF) would have numerous benefits in medicine. Tradition-
ally, respiratory-based methods require breathing maneuvers, partial 
rebreathing, or foreign gas mixing because exhaled CO2 volume on 
a per-breath basis does not accurately represent alveolar exchange of 
CO2. We hypothesized that if the dilutional effect of the functional 
residual capacity was accounted for, the relationship between the cal-
culated volume of CO2 removed per breath and the alveolar partial 
pressure of CO2 would be reversely linear.
Methods: A computer model was developed that uses variable tidal 
breathing to calculate CO2 removal per breath at the level of the al-
veoli. We iterated estimates for functional residual capacity to create 
the best linear fit of alveolar CO2 pressure and CO2 elimination for 10 
minutes of breathing and incorporated the volume of CO2 elimination 
into the Fick equation to calculate PBF.
Results: The relationship between alveolar pressure of CO2 and CO2 
elimination produced an R2 = 0.83. The optimal functional residual 
capacity differed from the “actual” capacity by 0.25 L (8.3%). The re-
peatability coefficient leveled at 0.09 at 10 breaths and the difference 
between the PBF calculated by the model and the preset blood flow 
was 0.62 ± 0.53 L/minute.
Conclusions: With variations in tidal breathing, a linear relationship 
exists between alveolar CO2 pressure and CO2 elimination. Existing 
technology may be used to calculate CO2 elimination during quiet 
breathing and might therefore be used to accurately calculate PBF in 
humans with healthy lungs.
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Introduction
A clinician’s ability to determine a patient’s cardiac output is 
critical in the assessment of cardiopulmonary health. Clini-
cally, this measurement can be required intermittently during 
surgery, as well as post-operatively. Cardiac output may also 
be measured in research settings, but doing so with invasive 
methods requires expensive critical care equipment, trained 
personnel, a sterile environment and readily available resus-
citative equipment.
Cardiac output is arguably one of the most important pa-
rameters reflecting cardiovascular health and yet its measure-
ment is currently limited to patients with Swan-Ganz catheters 
in the operating room, critical and intensive care units. To 
date, no non-invasive method has proven itself comparable to 
thermodilution in accuracy, repeatability, and in physiological 
soundness [1, 2]. Nevertheless, the thermodilution method is 
plagued with limitations in clinical practice, the most impor-
tant ones being associated with its invasiveness [3].
Methods for measuring cardiac output non-invasively can 
be  classified  as  respiratory-based  or  non-respiratory-based. 
The latter, which includes Doppler (external, transtracheal and 
transesophageal), bioimpedance, and pulse contour analysis, 
has not yet been accepted into clinical practice because of ei-
ther theoretical or practical limitations [4]. Additionally, there 
are some respiratory-based methods that utilize foreign gas 
breathing, including argon and acetylene, but these methods 
require a source of external gas, are impractical in many set-
tings, and will not be dealt with in detail here [5].
The respiratory-based methods are the oldest, the most 
physiologically  sound,  and  traditionally  the  most  accepted 
method of cardiac output measurement. Their principles and 
assumptions are well understood as are their limitations, the 
most important of which is that they more accurately meas-
ure pulmonary blood flow (PBF) rather than cardiac output. 
Originally described for oxygen, Fick equation, developed in 
the late 1800s, is based on the measurement of elements of 
the mass balance across the lungs [6]. The following is the Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org 84
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equivalent equation describing the movement of carbon diox-
ide (CO2):
Eq. 1:   PBF = VCO2/(CvCO2 - CaCO2)
where PBF is the pulmonary blood flow, VCO2 is the met-
abolic CO2 production, and CvCO2 and CaCO2 are the con-
centrations of CO2 in the blood entering (mixed venous, v) and 
leaving (arterial, a) the lungs respectively. To keep the method 
purely non-invasive, alveolar pressure is conventionally used 
as a surrogate for content. The relationship between PaCO2 
and CaCO2 is usually assumed to be linear in the physiologic 
range, and through previous in-vitro, CO2 content of oxygenat-
ed blood can be estimated using the following equation [7, 8]:
Eq. 2:   Content = 4 × Pressure + 260
Generally,  PaCO2  is  approximated  from  alveolar  CO2 
pressure (PACO2), which in turn is approximated from end-
tidal CO2 pressure (PETCO2). Mixed venous pressure of CO2 
(PvCO2) however, is difficult to obtain non-invasively, and 
has classically posed the biggest challenge to measurement of 
PBF. Respiratory maneuvers such as breathholding and rapid 
equilibration with external reservoirs have been employed to 
estimate PvCO2, but these have the disadvantage of requiring 
an external supply of CO2, and may pose a challenge to pa-
tients with respiratory compromise [9]. Single-breath methods 
have been presented, but none has proven itself repeatable and 
accurate.
In 1980, a novel method of calculating PBF without the 
need for measuring CvCO2 was described by Gedeon et al [9]. 
That method demonstrated that if a subject’s alveolar ventila-
tion (VA) were acutely and transiently reduced, a step change 
in PACO2 and VCO2 would result (once steady state is reached, 
after a few breaths). At this point, assuming PBF and PvCO2 
had not changed in this short time (< 30 - 45 s), two Fick equa-
tions could be applied to the model:
Eq. 3a:   PBF = VCO2/(S × PvCO2 - S × PACO2)
Eq. 3b:   PBF = VCO2’/(S × PvCO2 - S × PACO2’)
where VCO2’ and PACO2’ are the exhaled CO2 volumes 
and alveolar CO2 pressures after a new steady state has oc-
curred, respectively, and S is a conversion constant to content. 
Since PvCO2 and PBF remain unchanged with this maneuver, 
these equations together yield a single equation:
Eq. 4:   PBF = (VCO2 - VCO2’)/(S × PACO2’ - S × PACO2)
This way, a small, temporary change in VA can be used 
to calculate PBF without the need for invasive monitors. This 
method has been proven reliable in intubated patients by mul-
tiple studies [10-12].
Creative as this method is; however, there are several limi-
tations to it. First, the time to reach the new steady state is a 
function of the subject’s VA and functional residual capacity 
(FRC). On average, this time is approximately 30 - 45 s, or 
about five breaths, which means that only two data points are 
used to calculate PBF before recirculation of arterial blood oc-
curs, limiting the method’s accuracy. Second, because VA is 
required to be transiently reduced, and because the normal 
variability of breathing creates noise in the measurement sig-
nal, this method is limited only to intubated patients. Finally, 
PACO2 must be allowed to re-equilibrate to steady state levels 
before a subsequent test can be performed, which may require 
an additional 60 - 120 s.
Materials and Methods
Flux of CO2 at the alveoli
The method proposed here redefines the term VCO2 as de-
scribed in Fick’s equation. According to conventional under-
standing, VCO2 is defined as the excretion of CO2 past the 
lips, measured with a pneumotachometer and CO2 monitor. 
However, exhaled CO2 on a breath-by-breath basis seldom re-
flects actual metabolic CO2 production or pulmonary capillary 
excretion into the lungs [13]. Instead, an average over several 
breaths is required for this estimation, as the FRC acts as a 
reservoir for CO2. For example, a large breath that expunges 
a large volume of CO2 past the lips would incorrectly reflect 
a large “production” of CO2. The Fick equation, therefore, 
Figure 1. The relationship between VCO2A and PACO2 is linear. The 
slope of this line is proportional to the pulmonary blood flow. An inter-
secting line can be drawn from the origin following the relationship VA = 
VCO2 × PACO2/713. The steady state point (A) for PACO2 and VCO2A is 
produced by the balance of CO2 diffusion into the alveoli and the flow 
of blood into the pulmonary capillaries. 
Figure 2. Gedeon’s method of reducing VA for several breaths acutely 
increases PACO2 and reduces VCO2A creating a new steady state point 
on the same line. Point A and point B can be used together to calculate 
the slope of the line, which is the pulmonary blood flow. Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org 85
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would be more physiologically accurate if the term VCO2 rep-
resented the continuous flux of CO2 from the blood into the al-
veoli (VCO2A), rather than the discrete, tidal excretion of CO2 
past the lips (VCO2M). Averaged over many breaths, VCO2M 
will accurately reflect VCO2A.
Relationship between VCO2A and PACO2
After redefining VCO2 in this manner, it becomes clear that 
there exists a linear relationship between the flux of CO2 out of 
the blood (VCO2A) and PACO2 (Fig. 1).
At steady state VCO2A and PACO2 produce a single point 
on this line. The slope of this line, PBF, is proportional to the 
PBF. A second theoretical line exists on this diagram, connect-
ing the origin with the steady state point. This second line is 
described by the basic physiologic equation:
Eq. 5:   VCO2A = VA × PACO2/713
where VA is the alveolar ventilation - the slope of the line. 
It becomes clear that VCO2A - not VCO2M - must be applied 
when describing these relationships, as washout of the FRC 
can confound the changes that relate these variables.
Gedeon’s method aims to use two steady state VCO2M 
points to determine the slope of the PBF line: one attained 
from the subject breathing at rest (where VCO2M only equals 
VCO2A if averaged over many breaths), and the second after a 
small change in VA (measured after 4 - 5 breaths, when, after 
a transient period, VCO2M is assumed to be equal to VCO2A). 
In an extreme case, if the breath were held for 30 s and a new 
steady state were reached, PACO2 would be equal to PvCO2, 
or the x-intercept (Fig. 2). This method can only measure two 
points because after 4 - 5 breaths of breathing at a second VA, 
recirculation would alter PvCO2. However, if VCO2A can be 
measured with each breath, one data point along this line could 
be produced with each exhalation, and the slope, PBF could 
be calculated with sequential breaths. Variations in VCO2A are 
needed to explore this line, and the slope of the second line, 
VA, would vary with each breath due to normal variations in 
tidal volume and respiratory frequency. Since VCO2A likely 
fluctuates little during quiet breathing (as opposed to VCO2M), 
variability of breathing, which was once the system “noise”, 
therefore becomes important for measurement of PBF.
Once this line is observed over multiple breaths, PBF can 
be calculated by extrapolating to the x-intercept, PvCO2, and 
calculating PBF using equation 1.
Method for calculating VCO2A
The  method  described  above  requires  calculation  of  the 
VCO2A, the flux of CO2 across the alveolar membrane. Cal-
culation for VCO2A has been described thoroughly elsewhere 
[13]. Briefly, a simple mass balance dictates that the flux of 
CO2 into the alveoli from the blood is related to the flux of CO2 
at the mouth and the change of CO2 stores in the lung:
Eq. 6:   VCO2A = VCO2M - ΔVCO2S
where VCO2A is the alveolar flux of CO2, VCO2M is the 
flux of CO2 at the mouth, and ΔVCO2S is the change in lung 
stores of CO2. VCO2M is easily measured using a metabolic 
cart, which integrates exhaled CO2 concentration and expira-
tory flow.
The change in lung stores of CO2 from breath 1 to breath 
2, ΔVCO2S, can be described as the sum of two terms describ-
ing the change in CO2 concentration at a constant VA, and the 
change in VA at a constant CO2 concentration:
Eq. 7:   ΔVCO2S = VA(PACO2’ - PACO2)/713 + PACO2’ΔVA
where ΔVCO2S is the change in alveolar stores of CO2, 
VA,1 is the alveolar volume at the end of breath 1, PACO2 and 
PACO2’ are the fractions of CO2 in the alveoli at the end of 
breaths 1 and 2, respectively and ΔVA is the change in alveolar 
volume from breath 1 to breath 2.
Computer simulation
For this study, a computer simulation of tidal breathing was 
designed to test the theory under ideal conditions using Micro-
soft Excel 2003 (Redmond, Washington, USA). Incremental 
calculations of lung CO2 volume were made for each 0.001 
min. Tidal breathing was simulated using variable inhaled and 
exhaled tidal volumes (±30%), allowing lung volume to re-
turn to a different FRC with each breath. Complete alveolar 
mixing was assumed, inspiratory and expiratory times were 
equal, inhalation and exhalation flows were linear, and alveo-
lar dead-space and shunt were assumed to be minimal. PACO2 
was recorded once per breath (the final PACO2 value at the end 
of exhalation) and VCO2M was calculated at the mouth during 
exhalation. The model was run over a period of 10 min (100 
breaths), and PACO2, VCO2M, Vt-in and Vt-out were recorded 
with each breath. VA for sequential breaths was calculated as 
VA’ = VA + Vt-in - Vt-out, where Vt-in and Vt-out are inhaled 
tidal volume and exhaled tidal volume, respectively. Detailed 
parameters are outlined in Table 1.
PACO2-ave versus PETCO2
As stated above, the diffusion of CO2 across the alveolar mem-
brane should form a linear relationship with the pressure of 
CO2 in the alveoli. Therefore, measurements of PETCO2, a sin-
gle sample taken at the end of exhalation, would be inappropri-
ate to use in equation 3 since it reflects an end-expiration value 
rather than an average (PACO2-ave). In the computer model, 
an average PACO2 is easy to calculate, but this is not the case 
clinically, when PETCO2 samples are the only measurements 
Table 1.  The Parameters Used in the Mathematical Model
Parameter Error Value
PvCO2 (mm Hg) None 50
Pulmonary blood flow (L/min) None 6
Tidal volume (mL) ±30% 500
Respiratory frequency (/min) None 12
FRC (L) None 3
PBF-preset (L/min) None 6Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org 86
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readily available non-invasively. To estimate PACO2-ave for a 
single breath using only non-invasive data, we back-calculated 
to the PACO2 that might exist at peak inhalation and averaged 
this with PETCO2. The PACO2 at peak inhalation might be es-
timated as:
Eq. 8:   (Volume of CO2 in Lung at End-Exhalation - Vol-
ume of CO2 Diffused during Exhalation + Exhaled Volume of 
CO2) × 713/Peak Alveolar Volume
Averaging this value with PETCO2 may produce a reasona-
ble estimate of PACO2-ave which can be applied in equation 1.
Calculation of VCO2A
VCO2S  was  calculated  using  equation  6  using  sequential 
breaths, ΔVA was assumed to be measurable without the need 
for nitrogen monitors (Vt-in and Vt-out were measurable), and 
VA was initially assumed to be 3 L. VCO2A was then calcu-
lated using equation 5. Using 10 min of breathing data, when 
PBF and PvCO2 were assumed to be in steady state, a plot of 
VCO2A versus PACO2 was created and R2 was calculated for 
Figure 3. Alveolar partial pressure of CO2 over a period of 2 min as predicted by the computer model. 
Figure 4. VCO2 over time as measured at the mouth (VCO2M, open circles), as pre-set by the model (VCO2A-model, open 
squares) and as calculated using the proposed method (VCO2A-calculated, closed circles). Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org 87
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the line of best fit. FRC was then iterated in increments of 0.25 
L from 2 L to 4 L to achieve the most optimal linear relation-
ship between VCO2A and PACO2.
Real-world adjustments
To simulate real-world measurements, error was introduced 
into each measurement (PACO2, Vt-in, Vt-out, VCO2M, Table 
1), consistent with manufacturer specifications [14] and calcu-
lation of PBF was repeated.
PBF comparisons
PBF was calculated from equation 3 using two techniques: 
first,  using  known  VCO2A  measurements  directly  from  the 
model (PBF-preset), calculated using actual diffusion of CO2 
across the alveolar membrane, and second, using VCO2M to 
calculate VCO2A using equation 5 (PBF-calc), which repre-
sents the strategy that might be used practically in subjects. 
In the either case, PBF would be calculated using equation 1 
where PvCO2 was attained by extrapolating to the x-intercept 
of a plot relating VCO2A and PACO2-ave. We determined the 
appropriate number of breaths required for accurate measure-
ment of PBF-calc, by increasing the number of breaths used 
to calculate the average PBF-calc until the repeatability was 
similar to that of thermodilution [15].
PBF-calc was assessed and evaluated using Bland-Altman 
analysis where the acceptable error was taken from prior estab-
lished theory [16].
Results
The model for tidal ventilation produces reasonable values for 
PACO2 over 10 min of breathing. Sample oscillations in PACO2 
and lung volume can be seen in Figure 3.
VCO2A tended to vary less over the course of 10 min 
of breathing than VCO2M, as can be seen in Figure 4. When 
VCO2A was plotted against PACO2-ave a linear relationship 
was revealed which was stronger than with PETCO2 (R = 0.83 
versus 0.74, Fig. 5).
Iterating FRC demonstrated that small deviations from the 
model value produced poorer relationships between VCO2A 
and PACO2 (Fig. 6). However, the optimal FRC achieved after 
iterating FRC was 3.25 L, which was 0.25 L (8.3%) greater 
than the actual FRC used in the model. Non-optimal FRCs did 
not significantly reduce the accuracy of the calculated PBF, but 
did increase its variability.
When PACO2-ave was used instead of PETCO2, the rela-
tionship was improved (R2 = 0.83 versus 0.74). PBF-calc was 
calculated using 10 breaths at a time (see repeatability below) 
by extrapolating the line in Figure 3 to the x-intercept (PvCO2) 
and applied into equation 1. Using this method, the difference 
between PBF-preset and PBF-calc was 0.62 ± 0.53 L/min.
Figure 7 shows that the repeatability coefficient fell from 
1.13 to 0.09 L/min as the number of breaths used to calculate 
PBF-calc increased from 2 to 30. The repeatability coefficient 
decreased and leveled at 0.09 when approximately 10 breaths 
were used to average calculation for PBF-calc. The repeatabil-
ity coefficient for thermodilution is likely between 0.4 and 0.6 
L/min [4, 15]), which is the equivalent of using 5 - 6 breaths 
to average PBF-calc measurements in the proposed method.
Figure 5. The relationship between VCO2A and PACO2 using end-tidal PCO2 (PETCO2, gray squares) versus time averaged CO2 
across the breath (PACO2-ave, closed circles). Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org 88
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Discussion
The most common method for cardiac output measurement 
involves indicator dilution, normally dyes and temperature. A 
dye, or cold saline, is typically injected via an invasive catheter 
into the pulmonary artery and the temporal profile of the con-
centration of the dye or the temperature of the blood is meas-
ured downstream. The profile of the indicator change over time 
is used to calculate the cardiac output. Over the last three dec-
ades, there has been a steady improvement in the technology 
required to manufacture the catheters and thermistors, and to 
analyze the indicator curves and calculate the cardiac output 
[17]. In addition, the expertise to place the catheters and look 
after catheterized patients has become widespread.
Nevertheless, there are at least three drawbacks necessari-
ly associated with these methods. First, pulmonary artery cath-
eters are inherently invasive and have associated complica-
tions including damage to the carotid artery, subclavian artery 
and lung, air emboli, pneumothorax, malignant arrhythmias 
and heart block, rupture of right atrium, right ventricle and/or 
pulmonary capillary, local infection and septicaemia, and more 
[3]. Second, they have many associated costs as a result of the 
requirement for critical care areas, equipment and personnel. 
Third, their accuracy is questionable, and can be less reliable 
and helpful as required for management of critically ill patients 
[18]. Despite these drawbacks, thermodilution methods con-
tinue to be widely used as less invasive alternatives are not suf-
ficiently accurate, not sufficiently robust, or too cumbersome 
to perform in a large variety of clinical settings [19].
In this study, a new non-invasive method of measuring 
PBF is introduced based on principles that are already accept-
ed in medicine. The Fick method for measuring PBF is well 
established and is considered one of the most accurate tech-
niques available. Until recently, however, the Fick technique 
could only be performed using blood samples despite numer-
ous attempts to measure PvCO2 non-invasively. The method of 
creating a step-change in VA is the only validated non-invasive 
Fick method of cardiac output measurement without a special 
maneuver required by the patient, but can only be used on 
patients ventilated by a mechanical ventilator, uses only two 
breaths for measurement ETC. If a spontaneously breathing 
patient is made to rebreathe previously exhaled gas, the minute 
ventilation will tend to increase in order to increase the vol-
ume of air entering the lungs for gas exchange. The method 
presented here would require no maneuver on the part of the 
subject, and no foreign or compressed gases.
The method outlined here describes an original relation-
ship between VCO2 and PACO2. Its principles are grounded in 
basic physiology, and its application may extend beyond that 
of PBF measurement. Since PACO2 relates directly to VCO2 
given a specific set of conditions, other variables that may in-
fluence these parameters such as alveolar dead space, may be 
measureable as well.
There  are  several  practical  limitations  of  this  method. 
First, this strategy for measuring PBF could not be achieved 
without a perfect, air-tight seal around the mouth, nose, or 
face. Any air lost would reduce the accuracy of Vt-in, Vt-out, 
or VCO2M. This may be inconvenient or impossible for some 
patients, depending on the presence of facial hair, anomalous 
anatomy, or trauma.
Figure 6. The R2 statistical parameter relating VCO2A to PACO2 varies depending on the original estimate of FRC. As the initial 
guess of FRC is increased, R2 reaches a peak, optimum point and then falls. Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org 89
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Figure 7. As few as two breaths can be used to calculate PBF but its reliability is increased as more breaths are incorporated into 
the calculation. Precision reaches a plateau at about 8 - 10 breaths. 
This model assumes that all exhaled gas had participated 
in exchange of CO2 with the blood. PACO2 may vary depending 
on differences in ventilation-to-perfusion matching throughout 
the lung [2, 20]. If some exhaled gas originated from alveo-
lar dead space, PETCO2 would underestimate PACO2 and as 
a result, PBF-calc would overestimate PBF. The significance 
of this was not quantified in this study, but theoretically, it is 
possible that iterations of alveolar dead space estimates can 
be coupled with the estimates of FRC to provide an optimal 
relationship between PACO2 and VCO2A. Still, deviations of 
PETCO2 from PACO2 may also be due to incomplete breaths 
during exhalation and not alveolar deap space per se. This also 
impacts the calculation for PACO2-ave, which will also be af-
fected by all of the above.
In this study, 10 min of breathing were permitted to achieve 
initial FRC estimate. At this point, it is unclear why the ideal 
FRC produced from the iterative process differed from that 
used in the model. Nevertheless, its impact on PBF-calc was 
marginal. Furthermore, the purpose of this extended period of 
breathing was to demonstrate the principle rather than practi-
cality. Follow-up studies in humans will be required to further 
explore this strategy.
The real-world error in measuring Vt, PETCO2, VCO2 was 
based on products currently available for purchase. These will 
vary depending on the manufacturer and may improve in the 
future, making this method more practical.
The accuracy of this method for measuring PBF was simi-
lar to others that have been proposed [15]. The repeatability 
demonstrated that 10 breaths were needed for optimal accuracy, 
a time slightly greater than would be required for a complete 
test of thermodilution (about 30 s) depending on respiratory 
frequency. However, one advantage of the proposed method in 
this respect is that measurements for PBF are continuous, and 
no time is needed for “reset”, as may be needed to washout 
indicator from the pulmonary artery for thermodilution.
Finally, whereas the accuracy of other respiratory-based 
non-invasive methods may be diminished by respiratory fluc-
tuations, the proposed method is enhanced by large changes 
in  tidal  volume  and  respiratory  frequency.  It  may  even  be 
suggested that a subject ought to be encouraged to take deep 
breaths,  or  sigh  to  exaggerate  the  variability  of  quiet  tidal 
breathing.
Conclusion
The study we describe here is safe, theoretically sound, and 
demonstrates acceptable accuracy and repeatability. It repre-
sents a potential advancement towards measurement of im-
portant  cardiopulmonary  parameters  that  may  be  clinically 
important in the management of both outpatients and those 
in-hospital. Further studies in humans are required to quantify 
and evaluate its strengths and limitations.
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